Patent · US Active

Compounds useful for treating disorders related to RET

US10035789B2 · kind B2 · utility

24Cited by
9References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2017
Grant dateJul 31, 2018
Priority date
Expiry dateJul 26, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.